Tlr9 agonist protects mice from radiation-induced gastrointestinal syndrome

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Saha, Subhrajit ^a   Bhanja, Payel ^a   Liu, Laibin ^a   Alfieri, Alan A ^a   Yu, Dong ^b   Kandimalla, Ekambar R ^b   Agrawal, Sudhir ^b   Guha, Chandan ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HYBRIDON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR 9 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; GASTROINTESTINAL AGENT; RADIOPROTECTIVE AGENT; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON TUMOR; CONTROLLED STUDY; GASTROINTESTINAL DISEASE; HISTOPATHOLOGY; INTESTINE; MALE; MORTALITY; MOUSE; NONHUMAN; PROGNOSIS; RADIATION INDUCED GASTROINTESTINAL SYNDROME; RADIATION INJURY; RAT; SURVIVAL; TUMOR GROWTH; WHOLE BODY RADIATION; XYLOSE TEST; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL PROTECTION; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; METABOLISM; RADIATION DOSE; SYNDROME; TUMOR CELL LINE;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS;

ANIMALS; CELL LINE, TUMOR; CYTOPROTECTION; DRUG EVALUATION, PRECLINICAL; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RADIATION INJURIES, EXPERIMENTAL; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; RATS; SYNDROME; TOLL-LIKE RECEPTOR 9;

EID: 84855405251     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029357     Document Type: Article

References (49)

1. Marshman E, Booth C, Potten CS, (2002) The intestinal epithelial stem cell. Bioessays 24: 91-98.
2. Potten CS, (1998) Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci 353: 821-830.
3. Booth D, Potten CS, (2001) Protection against mucosal injury by growth factors and cytokines. J Natl Cancer Inst Monogr pp. 16-20.
4. Booth D, Haley JD, Bruskin AM, Potten CS, (2000) Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem-cell cycling. Int J Cancer 86: 53-59.
5. Khan WB, Shui C, Ning S, Knox SJ, (1997) Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Radiat Res 148: 248-253.
6. Maj JG, Paris F, Haimovitz-Friedman A, Venkatraman E, Kolesnick R, et al. (2003) Microvascular function regulates intestinal crypt response to radiation. Cancer Res 63: 4338-4341.
7. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, et al. (2001) Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293: 293-297.
8. Rotolo JA, Maj JG, Feldman R, Ren D, Haimovitz-Friedman A, et al. (2008) Bax and Bak do not exhibit functional redundancy in mediating radiation-induced endothelial apoptosis in the intestinal mucosa. Int J Radiat Oncol Biol Phys 70: 804-815.
9. Okunieff P, Mester M, Wang J, Maddox T, Gong X, et al. (1998) In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiat Res 150: 204-211.
10. Zhang L, Sun W, Wang J, Zhang M, Yang S, et al. (2010) Mitigation effect of an FGF-2 peptide on acute gastrointestinal syndrome after high-dose ionizing radiation. Int J Radiat Oncol Biol Phys 77: 261-268.
11. Packey CD, Ciorba MA, (2010) Microbial influences on the small intestinal response to radiation injury. Curr Opin Gastroenterol 26: 88-94.
12. Stenson WF, (2008) Toll-like receptors and intestinal epithelial repair. Curr Opin Gastroenterol 24: 103-107.
13. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R, (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
14. Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS, (2005) Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci U S A 102: 99-104.
15. Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, et al. (2008) An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320: 226-230.
16. Gribar SC, Sodhi CP, Richardson WM, Anand RJ, Gittes GK, et al. (2009) Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol 182: 636-646.
17. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, et al. (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49.
18. Kandimalla ER, Bhagat L, Wang D, Yu D, Zhu FG, et al. (2003) Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles. Nucleic Acids Res 31: 2393-2400.
19. Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, et al. (2005) Immunomodulatory oligonucleotides containing a cytosine-phosphate-2′-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists. Proc Natl Acad Sci U S A 102: 6925-6930.
20. Yu D, Putta MR, Bhagat L, Li Y, Zhu F, et al. (2007) Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs. J Med Chem 50: 6411-6418.
21. Yu D, Zhao Q, Kandimalla ER, Agrawal S, (2000) Accessible 5′-end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity. Bioorg Med Chem Lett 10: 2585-2588.
22. Kandimalla ER, Bhagat L, Yu D, Cong Y, Tang J, et al. (2002) Conjugation of ligands at the 5′-end of CpG DNA affects immunostimulatory activity. Bioconjug Chem 13: 966-974.
23. Putta MR, Zhu FG, Wang D, Bhagat L, Dai M, et al. (2010) Peptide conjugation at the 5′-end of oligodeoxynucleotides abrogates toll-like receptor 9-mediated immune stimulatory activity. Bioconjug Chem 21: 39-45.
24. Wang D, Li Y, Yu D, Song SS, Kandimalla ER, et al. (2004) Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs. Int J Oncol 24: 901-908.
25. Damiano V, Caputo R, Bianco R, D'Armiento FP, Leonardi A, et al. (2006) Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors. Clin Cancer Res 12: 577-583.
26. Damiano V, Caputo R, Garofalo S, Bianco R, Rosa R, et al. (2007) TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts. Proc Natl Acad Sci U S A 104: 12468-12473.
27. Damiano V, Garofalo S, Rosa R, Bianco R, Caputo R, et al. (2009) A novel toll-like receptor 9 agonist cooperates with trastuzumab in trastuzumab-resistant breast tumors through multiple mechanisms of action. Clin Cancer Res 15: 6921-6930.
28. Rosa R, Melisi D, Damiano V, Bianco R, Garofalo S, et al. (2011) Toll-like Receptor 9 Agonist IMO Cooperates with Cetuximab in K-Ras Mutant Colorectal and Pancreatic Cancers. Clin Cancer Res 17: 6531-6541.
29. Kandimalla ER, Agrawal S, (2011) Modulation of Endosomal Toll-Like Receptor-Mediated Immune Responses by Synthetic Oligonucleotides.
30. Yu D, Kandimalla ER, Bhagat L, Tang JY, Cong Y, et al. (2002) 'Immunomers'-novel 3′-3′-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents. Nucleic Acids Res 30: 4460-4469.
31. Potten CS, (1990) A comprehensive study of the radiobiological response of the murine (BDF1) small intestine. Int J Radiat Biol 58: 925-973.
32. Potten CS, Merritt A, Hickman J, Hall P, Faranda A, (1994) Characterization of radiation-induced apoptosis in the small intestine and its biological implications. Int J Radiat Biol 65: 71-78.
33. Potten CS, (1992) The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev 11: 179-195.
34. Eberts TJ, Sample RH, Glick MR, Ellis GH, (1979) A simplified, colorimetric micromethod for xylose in serum or urine, with phloroglucinol. Clin Chem 25: 1440-1443.
35. Potten CS, Booth D, Haley JD, (1997) Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer 75: 1454-1459.
36. Bhanja P, Saha S, Kabarriti R, Liu L, Roy-Chowdhury N, et al. (2009) Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice. PLoS One 4: e8014.
37. Milas L, Mason KA, Ariga H, Hunter N, Neal R, et al. (2004) CpG oligodeoxynucleotide enhances tumor response to radiation. Cancer Res 64: 5074-5077.
38. Gudkov AV, Komarova EA, (2010) Radioprotection: smart games with death. J Clin Invest 120: 2270-2273.
39. Rao B, van Leeuwen IM, Higgins M, Campbel J, Thompson AM, et al. (2010) Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy. Oncotarget 1: 639-650.
40. Raffaghello L, Safdie F, Bianchi G, Dorff T, Fontana L, et al. (2010) Fasting and differential chemotherapy protection in patients. Cell Cycle 9: 4474-4476.
41. Apontes P, Leontieva OV, Demidenko ZN, Li F, Blagosklonny MV, (2011) Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture. Oncotarget 2: 222-233.
42. Tavana O, Benjamin CL, Puebla-Osorio N, Sang M, Ullrich SE, et al. (2010) Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence. Cell Cycle 9: 3328-3336.
43. Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, et al. (2006) Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor- and cycle-arrest-mediated cytoprotection. Cell Death Differ 13: 1434-1441.
44. Crawford PA, Gordon JI, (2005) Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci U S A 102: 13254-13259.
45. Egan LJ, Eckmann L, Greten FR, Chae S, Li ZW, et al. (2004) IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci U S A 101: 2452-2457.
46. Garin-Laflam MP, Steinbrecher KA, Rudolph JA, Mao J, Cohen MB, (2009) Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis. Am J Physiol Gastrointest Liver Physiol 296: G740-749.
47. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528.
48. Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, et al. (2006) Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8: 1327-1336.
49. Daroczi B, Kari G, Ren Q, Dicker AP, Rodeck U, (2009) Nuclear factor kappaB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos. Mol Cancer Ther 8: 2625-2634.